New targeted-colon delivery system: in vitro and in vivo evaluation using X-ray imaging

References

• Abou-Aiad HM, Abd-El-Nour KN, Hakim IK, Elsabee MZ. (2006). Dielectric and interaction behavior of chitosan/polyvinyl alcohol and chitosan/polyvinyl pyrrolidone blends with some antimicrobial activities. Polymer 47(1), 379–389.
   Web of Science ®Google Scholar
• Alanazi FK, Yassin AB, El-Badry M, Mowafy HA, Alsarra IA. (in press). Validated high performance liquid chromatographic technique for determination of 5-fluorouracil: applications to stability studies and simulated colonic media. J Chromat Sci, 47.
   Google Scholar
• Alsarra IA, Alarifi MN. (2004). Validated liquid chromatographic determination of 5-fluorouracil in human plasma. J. Chromatogr B Analyt Technol Biomed Life Sci, 804, 435–439.
   PubMed Web of Science ®Google Scholar
• Ashford M, Fell JT. (1994). Targeting drugs to the colon: delivery systems for oral administration. J Drug Target 2, 241–258.
   PubMed Web of Science ®Google Scholar
• Calabresi P, Chabner BA. (1996). Chemotherapy of neoplastic diseases. In: Limbird JG, Perry LE, Raymond BM, eds. Goodman and Gilman’s the Pharmacological Basis of Therapeutics (pp. 1225–1232 ). New Delhi: McGraw-Hill.
   Google Scholar
• Cancer Incidence Report, National Cancer Registry, Ministry of Health, Saudi Arabia, 2003.
   Google Scholar
• Casale F, Canaparo R, Serpe L, Muntoni E, Pepa CD, Costa M, Mairone L, Zara GP, Fornari G, Eandi M. (2004). Plasma concentrations of 5-fluorouracil and its metabolites in colon cancer patient. Pharmacol Res 50, 173–179.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention, web-based report released in 2005: Http://www.cdc.gov/cancer/colorectal/statistics.
   Google Scholar
• Chourasia S, Jain S. (2003). Pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Pharm Sci, 6, 33–66.
   PubMed Web of Science ®Google Scholar
• Devi DA, Smitha B, Sridhar S, Aminabhavi, TM. (2006). Novel crosslinked chitosan/poly(vinylpyrrolidone) blend membranes for dehydrating tetrahydrofuran by the pervaporation technique. J Memb Sci, 1, 45–53.
   Google Scholar
• Diasio RB, Harris BE. (1989). Clinical pharmacology of 5-fluorouracil. Clin Pharmacokinet, 16, 215–237.
   PubMed Web of Science ®Google Scholar
• Davis LE, Krawczeniuk MM. (1997). Colorectal cancer. In: Dipiro JT, ed. Pharmacotherapy a Pathophysiologica Approach (pp. 2513–2538 ). New Jersey: Prentice Hall.
   Google Scholar
• Grag MB, Sevesster JC, Sakoff JA, Ackland SP. (2002). Simple liquid chromatographic method for the determination of uracil and dihydrouracil plasma levels: a potential pretreatment predictor of 5-fluorouracil toxicity. J Chromatogr B Biomed Sci Appl, 774, 223–230.
   Web of Science ®Google Scholar
• Hahn RG, Moertel CG, Schutt AJ. (1975). A double-blind comparison of intensive course 5-fluorouracil by oral vs. intravenous route in the treatment of colorectal carcinoma. Cancer, 35, 1031–1035.
   Google Scholar
• Khoo CGL, Frantzich S, Rosinski A, Sjöström M, Hoogstraate J. (2003). Oral gingival delivery systems from chitosan blends with hydrophilic polymers. Eur J Pharm Biopharm, 55(1), 47–56.
   PubMed Web of Science ®Google Scholar
• Krishnaiah YS, Satyanarayana V, Dinesh Kumar B, Karthikyan RS. (2002). In vitro drug release studies on guar gum-based colon targeted oral drug delivery systems of 5-fluorouracil. Eur J Pharm Sci, 16, 185–192.
   PubMed Web of Science ®Google Scholar
• Lamprecht A, Yamamoto H, Takeuchi H, Kawashima Y. (2003). Microsphere design for the colonic delivery of 5-fluorouracil. J Control Release, 90, 313–322.
   PubMed Web of Science ®Google Scholar
• Liu L, Fishman ML, Kost J, Hicks KB. (2003). Pectin-based systems for colon-specific drug delivery via oral route. Biomaterials, 24, 3333–3343.
   PubMed Web of Science ®Google Scholar
• Micoli G, Turci R, Arpellini M, Minoia C. (2001). Determination of 5-fluorouracil in environmental samples by solid-phase extraction and high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Sci Appl, 750, 25–32.
   PubMedGoogle Scholar
• Minko T. (2004). Drug targeting to the colon with lectins and neoglycoconjugates. Adv Drug Deliv Rev 56, 491–509.
   PubMed Web of Science ®Google Scholar
• Omar S, Aldosari B, Refai H, Al Gohary O. (2007). Colon-specific drug delivery for mebeverine hydrochloride. J Drug Target, 15, 691–700.
   PubMed Web of Science ®Google Scholar
• Paharia AK, Yadav G, Rai S, Jain SK, Pancholi SS, Agrawal P. (2007). Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting. AAPS PharmSciTech, 8, E1–E7.
   PubMed Web of Science ®Google Scholar
• Parker SL, Tong T, Bolden S, Wingo PA. (1996). Cancer statistics. CA Cancer J Clin, 65, 5–27.
   Web of Science ®Google Scholar
• Potter JD. (1999). Colorectal cancer: molecules and populations. J Natl Cancer Inst, 91, 916–932.
   PubMed Web of Science ®Google Scholar
• Reddy S, Sinha V, Reddy D. (1999). Novel oral colon-specific drug delivery systems for pharmacotherapy of peptide and nonpeptide drugs. Drugs Today, 35, 537–580.
   PubMed Web of Science ®Google Scholar
• Risbud MV, Hardikar AA, Sujata V, Bhat SV, Bhonde RR. (2000). pH-sensitive freeze-dried chitosan–polyvinyl pyrrolidone hydrogels as controlled release system for antibiotic delivery. J Control Release, 68(1), 23–30.
   PubMed Web of Science ®Google Scholar
• Sinha VR, Mittal BR, Bhutani KK, Rachna K. (2004). Colonic drug delivery of 5-fluorouracil: an in vitro evaluation. Int J Pharm, 269,101–108.
   PubMed Web of Science ®Google Scholar
• Sinha VR, Mittal BR, Kumria R. (2005). In vivo evaluation of time and site of disintegration of polysaccharide tablet prepared for colon-specific drug delivery. Int J Pharm, 289, 79–85.
   PubMed Web of Science ®Google Scholar
• Tuğcu-Demiröz F, Acartürk F, Takka S, Konuş-Boyunağa O. (2007). Evaluation of alginate based mesalazine tablets for intestinal drug delivery. Eur J Pharm Biopharm, 67, 491–497.
   PubMed Web of Science ®Google Scholar
• United States Pharmacopoeia-XXIII, National Formulary-XVIII. (1995). United States Pharmacopeial Convention Inc. (pp. 1625–1626 ). Rockville, MD: Twin Brook Parkway.
   Google Scholar
• Van den Mooter G, Samyn C, Kinget R. (1995). In vivo evaluation of a colon-specific drug delivery system: an absorption study of theophylline from capsules coated with azo polymers in rats. Pharm Res, 12, 244–247.
   PubMed Web of Science ®Google Scholar
• Viñas-Salas J, Biendicho-Palau P, Piñol-Felis C, Miguelsanz-Garcia S, Perez-Holanda S. (1998). Calcium inhibits colon carcinogenesis in an experimental model in the rat. Eur J Cancer, 34, 1941–1945.
   PubMed Web of Science ®Google Scholar
• Yang L, Chu JS, Fix JA. (2002). Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int J Pharm, 235, 1–15.
   PubMed Web of Science ®Google Scholar
• Yassin AE. (2003). Colonic targeting using chitosan and chitosan/pectin mixtures: an in-vitro evaluation. Egypt J Biomed Sci, 12, 174–183.
   Google Scholar
• Yassin AE, Dallia AR, Kassem AE. (2003). Comparative bioavailability of two tablet formulations of metronidazole in human volunteers: an assessment of colonic targeting. Egypt J Biomed Sci, 12, 40–48.
   Google Scholar
• Zambito Y, Baggiani A, Carelli V, Serafini MF, Di Colo G. (2005). Matrices for site-specific controlled-delivery of 5-fluorouracil to descending colon. J Control Release, 102, 699–677.
   PubMedGoogle Scholar
• Zhang H, Alsarra IA, Neau SH. (2002). An in vitro evaluation of a chitosan-containing multiparticulate system for macromolecule delivery to the colon. Int J Pharm, 239, 197–205.
   PubMed Web of Science ®Google Scholar